OLFM4 and pancreatic ductal adenocarcinoma: However, it has been reported that, in pancreatic ductal adenocarcinomas, OLFM4 expression was up-regulated in the poor-prognosis group, and high expression of OLFM4 correlated significantly with lower overall survival [34].